NL7506743A - Diagnosticum. - Google Patents

Diagnosticum.

Info

Publication number
NL7506743A
NL7506743A NL7506743A NL7506743A NL7506743A NL 7506743 A NL7506743 A NL 7506743A NL 7506743 A NL7506743 A NL 7506743A NL 7506743 A NL7506743 A NL 7506743A NL 7506743 A NL7506743 A NL 7506743A
Authority
NL
Netherlands
Prior art keywords
june
blood plasma
water
intravascularly
subsequent
Prior art date
Application number
NL7506743A
Other languages
English (en)
Dutch (nl)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NL7506743A publication Critical patent/NL7506743A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7506743A 1974-06-06 1975-06-06 Diagnosticum. NL7506743A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (1)

Publication Number Publication Date
NL7506743A true NL7506743A (nl) 1975-12-09

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7506743A NL7506743A (nl) 1974-06-06 1975-06-06 Diagnosticum.

Country Status (8)

Country Link
JP (1) JPS517113A (enrdf_load_stackoverflow)
AU (1) AU8164675A (enrdf_load_stackoverflow)
CA (1) CA1039274A (enrdf_load_stackoverflow)
DE (1) DE2524278A1 (enrdf_load_stackoverflow)
FR (1) FR2273516A1 (enrdf_load_stackoverflow)
GB (1) GB1518813A (enrdf_load_stackoverflow)
NL (1) NL7506743A (enrdf_load_stackoverflow)
SE (1) SE420566B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001738A1 (en) * 1981-11-12 1983-05-26 SCHRÖDER, Ulf Intravascularly administrable, magnetically responsive nanosphere or manoparticle, a process for the production thereof, and the use thereof
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel

Also Published As

Publication number Publication date
JPS517113A (enrdf_load_stackoverflow) 1976-01-21
FR2273516A1 (fr) 1976-01-02
SE420566B (sv) 1981-10-19
DE2524278A1 (de) 1975-12-18
AU8164675A (en) 1976-12-02
GB1518813A (en) 1978-07-26
CA1039274A (en) 1978-09-26
SE7407461L (sv) 1975-12-08
FR2273516B1 (enrdf_load_stackoverflow) 1979-01-05

Similar Documents

Publication Publication Date Title
EP0787017B2 (en) Diagnostic preparation for detection of helicobacter pylori
CA1165686A (en) Radioactive diagnostic agent and non-radioactive carrier therefor
JPS60155138A (ja) 高められた腸内吸収性を有するヘパリン製剤の製造方法及び該ヘパリン製剤
CA1063932A (en) Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled canning agents: liver scanning technetium-99m colloid and method of preparation
Whitby Enzymic formation of a new riboflavin derivative
SE420566B (sv) Diagnostiseringsmedel for intravaskuler administrering
Schilsky et al. Biliary copper excretion capacity in intact animals: correlation between ATP7B function, hepatic mass, and biliary copper excretion
Ekenved ABSORPTION FROM DIFFERENT TYPES OF IRON TABLETS‐CORRELATION BETWEEN SERUM IRON INCREASE AND TOTAL ABSORPTION OF IRON
EP0063946A1 (en) Diagnosis of kidney function
DE69001000T2 (de) Radioaktives diagnosemittel.
Esquerre et al. Kinetics of technetium-labeled heparin in thromboembolism: Preliminary report
EP0280135A2 (de) Protein C-Inhibitor (PCI) als Pharmazeutikum und Diagnostikum, Verfahren zu Herstellung eines solchen Pharmazeutikums oder Diagnostikums sowie ein Mittel enthaltend PCI
Caputo et al. Letterer-Siwe disease in an octogenarian
JPS5842846B2 (ja) 肝臓および骨髄走査用テクネチウム−９９ｍ標識放射線診断剤とその製造法
Balaban et al. Effect of the radiolabel mediator tropolone on lymphocyte structure and function
Hudson et al. Tumour uptake of thallium-201 chloride
Turan et al. Evaluation of 99mTc-citrate, 67Gacitrate and 99mTc (V) dimercaptosuccinic acid for the scintigraphic visualization of acute appendicitis
Rosenau Dangers in the use of certain halogenated phthaleins as functional tests
Feinendegen et al. On behalf of I-123 fatty acids for myocardial metabolic imaging
JPS63170400A (ja) 放射性医薬品とその調製用高分子化合物
GB2055044A (en) Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases
Duchon Tyrosine metabolism in melanoma
Mouna et al. Sterility Testing and Contamination Analysis of the 99mTc Eluates from RIPDTEC Mo-99/Tc-99m Chromatographic Column Generator
JPS60126231A (ja) 放射性診断剤
Perin et al. Evaluation of possible interference of anti-inflammatory drugs upon scintigraphic imaging with macrophage targeting 99mTc-J001X: Effects of methylprednisolone, dexamethasone, indomethacin and methotrexate

Legal Events

Date Code Title Description
BV The patent application has lapsed